Michele Ceribelli

8PUBLICATIONS
111CO-AUTHORS
Metabolic medicineMolecular targetsCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 17, 2026
Cysteine-mediated bortezomib resistance is governed by α-ketoacid availability.

|Oct 03, 2025
Multiple Epigenetic Mechanisms Functionally Cooperate to Silence Expression of Somatostatin Receptor Type 2 in Pancreatic Neuroendocrine Tumors.

James P Madigan, Stephen G Andrews, Rivka B Farrell

|Jul 24, 2025
Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7-Expressing CRPC Models.

Benjamin C Brim, Andres F Leon, Erica L Beatson

|Oct 14, 2024
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82.

Susana S Najera, Christopher J Ricketts, Laura S Schmidt

|Mar 07, 2024
Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts.

Yasuhiro Arakawa, Ukhyun Jo, Suresh Kumar

|May 22, 2023
Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.

Junko Murai, Michele Ceribelli, Haiqing Fu

Pageof 2

Frequent Collaborators

7 joint publications

Craig Thomas

4 joint publications

Kelli Wilson

4 joint publications

Xiaohu Zhang

4 joint publications

Carleen Klumpp-Thomas